vimarsana.com

Latest Breaking News On - Devices number - Page 1 : vimarsana.com

Global Neuromodulation Devices Market Research Report 2023 Featuring Abbott, Axonics, Bioventus, Boston Scientific, Inspire Medical, Laborie Medical, Livanova, Medtronic, Neuropace, Nevro

/PRNewswire/ The "Neuromodulation Devices Global Market- Forecast To 2029" report has been added to ResearchAndMarkets.com s offering. The neuromodulation.

United statesNevro corpoartionLaura woodLaborie medical system incBiowave corporationSurgery centersLivanova plcNeurolief ltdMedtronic plcAvery biomedical devices incNeurosigma incWearable neuromodulation technologyNeuropace incLocala healthOffice hours callPhysiotherapy centers

$4 16 Billion Neurovascular Intervention Devices Market - Global Forecast to 2027 - Acquisitions and Partnerships as a Part of the Growth Strategy

Share this article Share this article ResearchAndMarkets.com s offering. The Neurovascular Intervention Devices global market is expected to grow at a high single digit CAGR to reach $4,167.4 million by 2027. Over the decade, due to the technological advancements with emerging and innovative technologies used under minimally invasive conditions has led to the rapid development of neurovascular interventions. As a result of rapid advances, there is the great expansion in the potential therapeutic application for neurovascular diseases. Neurovascular Interventional devices are used to treat intracranial aneurysm, ischemic stroke, arteriovenous malformation, carotid stenosis and other diseases like intracranial stenosis, dural fistula. The market is primarily driven by the increase in incidence and prevalence of neurovascular diseases like intracranial aneurysm, stroke and arteriovenous malformations, increase in the aging population, technological advancement, acquisitions and fa

United statesDeutschland verwaltungs gmbLaura woodCerus endovascularJohnson cerenovusMedtronic public limited companyKaneka pharma americaCeretrieve ltd israelArtio medical incPorters five force analysisStryker corporationTherapeutics incMonarch biosciences incCerevasc incCardinal health incOffice hours call

Global Orthopaedic Devices Markets, 2020-2027: Evolution in the Robotic-Assisted Surgery With Smaller Incision and Post-Operative Care Reduction

Share this article Share this article ResearchAndMarkets.com s offering. The orthopaedic devices global market is expected to reach $53,607.2 million by 2027 growing at a high single digit CAGR. Over the decade, due to the technological advancements with emerging and innovative technologies used under minimally invasive conditions has led to the rapid development of orthopaedic device. As a result of rapid advances, there is great expansion in the potential therapeutic application for musculoskeletal injuries, deformities and diseases. The market is primarily driven by the increase in incidence and prevalence of musculoskeletal diseases such as osteoarthritis, osteoporosis, spinal degenerative diseases, spondylitis, lower back pain, herniated spinal discs, and injuries due to trauma and sports activities, increase in the aging population, technological advancement, acquisitions and factors such as product recall, complications associated with implanted devices, lack of skilled

Johnson depuy synthesB braun melsungenLaura woodMedtronic public limited companyDevelopment of patientStryker corporationNuvasive incColfax corporation djoZimmer biomet holdings incPorter five force analysisCustom researchGlobus medical incRegulatory affairsOffice hours callMajor companiesSurgical centers

vimarsana © 2020. All Rights Reserved.